Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder

Lori L. Altshuler, Osama A. Abulseoud, Lara Foland-Ross, George Bartzokis, Sean Chang, Jim Mintz, Gerhard Hellemann, Harry V. Vinters

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Objectives: Several magnetic resonance imaging studies have found changes in amygdala volumes in adults with mood disorders. The cellular basis for these changes has not been explored in detail. Specifically, it is not known whether differences in the density and/or volume of neurons or glial cells contribute to tissue volume changes seen on magnetic resonance images. Methods: Postmortem amygdala samples were obtained from the Stanley Foundation Neuropathology Consortium from subjects diagnosed with bipolar disorder (n = 10), major depressive disorder (n = 11), and schizophrenia (n = 9), and from normal controls (n = 14). Samples were first stained with glial fibrillary acidic protein (GFAP) and counter-stained with hematoxylin to ascertain neuron and glia (astrocyte) densities. Results: No significant differences in neuronal densities were found between groups. However, a reduction in the density of GFAP immunoreactive astrocytes was observed in the amygdala of subjects with major depressive disorder compared to the bipolar disorder, schizophrenia, and normal control postmortem samples. Conclusions: A decrease in density of GFAP immunoreactive astrocytes in the amygdala of depressed subjects is consistent with prior histologic reports and might contribute to amygdala volume reductions reported in several in vivo neuroimaging studies.

Original languageEnglish (US)
Pages (from-to)541-549
Number of pages9
JournalBipolar Disorders
Volume12
Issue number5
DOIs
StatePublished - Aug 2010
Externally publishedYes

Fingerprint

Major Depressive Disorder
Amygdala
Bipolar Disorder
Astrocytes
Glial Fibrillary Acidic Protein
Neuroglia
Schizophrenia
Neurons
Hematoxylin
Mood Disorders
Neuroimaging
Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging

Keywords

  • Amygdala
  • Astrocyte
  • Bipolar disorder
  • Depression
  • Glial cell
  • Neuron

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Altshuler, L. L., Abulseoud, O. A., Foland-Ross, L., Bartzokis, G., Chang, S., Mintz, J., ... Vinters, H. V. (2010). Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. Bipolar Disorders, 12(5), 541-549. https://doi.org/10.1111/j.1399-5618.2010.00838.x

Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. / Altshuler, Lori L.; Abulseoud, Osama A.; Foland-Ross, Lara; Bartzokis, George; Chang, Sean; Mintz, Jim; Hellemann, Gerhard; Vinters, Harry V.

In: Bipolar Disorders, Vol. 12, No. 5, 08.2010, p. 541-549.

Research output: Contribution to journalArticle

Altshuler, LL, Abulseoud, OA, Foland-Ross, L, Bartzokis, G, Chang, S, Mintz, J, Hellemann, G & Vinters, HV 2010, 'Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder', Bipolar Disorders, vol. 12, no. 5, pp. 541-549. https://doi.org/10.1111/j.1399-5618.2010.00838.x
Altshuler LL, Abulseoud OA, Foland-Ross L, Bartzokis G, Chang S, Mintz J et al. Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. Bipolar Disorders. 2010 Aug;12(5):541-549. https://doi.org/10.1111/j.1399-5618.2010.00838.x
Altshuler, Lori L. ; Abulseoud, Osama A. ; Foland-Ross, Lara ; Bartzokis, George ; Chang, Sean ; Mintz, Jim ; Hellemann, Gerhard ; Vinters, Harry V. / Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. In: Bipolar Disorders. 2010 ; Vol. 12, No. 5. pp. 541-549.
@article{2a4b0ba2edc34732a8b9b3ea074e30d5,
title = "Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder",
abstract = "Objectives: Several magnetic resonance imaging studies have found changes in amygdala volumes in adults with mood disorders. The cellular basis for these changes has not been explored in detail. Specifically, it is not known whether differences in the density and/or volume of neurons or glial cells contribute to tissue volume changes seen on magnetic resonance images. Methods: Postmortem amygdala samples were obtained from the Stanley Foundation Neuropathology Consortium from subjects diagnosed with bipolar disorder (n = 10), major depressive disorder (n = 11), and schizophrenia (n = 9), and from normal controls (n = 14). Samples were first stained with glial fibrillary acidic protein (GFAP) and counter-stained with hematoxylin to ascertain neuron and glia (astrocyte) densities. Results: No significant differences in neuronal densities were found between groups. However, a reduction in the density of GFAP immunoreactive astrocytes was observed in the amygdala of subjects with major depressive disorder compared to the bipolar disorder, schizophrenia, and normal control postmortem samples. Conclusions: A decrease in density of GFAP immunoreactive astrocytes in the amygdala of depressed subjects is consistent with prior histologic reports and might contribute to amygdala volume reductions reported in several in vivo neuroimaging studies.",
keywords = "Amygdala, Astrocyte, Bipolar disorder, Depression, Glial cell, Neuron",
author = "Altshuler, {Lori L.} and Abulseoud, {Osama A.} and Lara Foland-Ross and George Bartzokis and Sean Chang and Jim Mintz and Gerhard Hellemann and Vinters, {Harry V.}",
year = "2010",
month = "8",
doi = "10.1111/j.1399-5618.2010.00838.x",
language = "English (US)",
volume = "12",
pages = "541--549",
journal = "Bipolar Disorders",
issn = "1398-5647",
publisher = "Blackwell Munksgaard",
number = "5",

}

TY - JOUR

T1 - Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder

AU - Altshuler, Lori L.

AU - Abulseoud, Osama A.

AU - Foland-Ross, Lara

AU - Bartzokis, George

AU - Chang, Sean

AU - Mintz, Jim

AU - Hellemann, Gerhard

AU - Vinters, Harry V.

PY - 2010/8

Y1 - 2010/8

N2 - Objectives: Several magnetic resonance imaging studies have found changes in amygdala volumes in adults with mood disorders. The cellular basis for these changes has not been explored in detail. Specifically, it is not known whether differences in the density and/or volume of neurons or glial cells contribute to tissue volume changes seen on magnetic resonance images. Methods: Postmortem amygdala samples were obtained from the Stanley Foundation Neuropathology Consortium from subjects diagnosed with bipolar disorder (n = 10), major depressive disorder (n = 11), and schizophrenia (n = 9), and from normal controls (n = 14). Samples were first stained with glial fibrillary acidic protein (GFAP) and counter-stained with hematoxylin to ascertain neuron and glia (astrocyte) densities. Results: No significant differences in neuronal densities were found between groups. However, a reduction in the density of GFAP immunoreactive astrocytes was observed in the amygdala of subjects with major depressive disorder compared to the bipolar disorder, schizophrenia, and normal control postmortem samples. Conclusions: A decrease in density of GFAP immunoreactive astrocytes in the amygdala of depressed subjects is consistent with prior histologic reports and might contribute to amygdala volume reductions reported in several in vivo neuroimaging studies.

AB - Objectives: Several magnetic resonance imaging studies have found changes in amygdala volumes in adults with mood disorders. The cellular basis for these changes has not been explored in detail. Specifically, it is not known whether differences in the density and/or volume of neurons or glial cells contribute to tissue volume changes seen on magnetic resonance images. Methods: Postmortem amygdala samples were obtained from the Stanley Foundation Neuropathology Consortium from subjects diagnosed with bipolar disorder (n = 10), major depressive disorder (n = 11), and schizophrenia (n = 9), and from normal controls (n = 14). Samples were first stained with glial fibrillary acidic protein (GFAP) and counter-stained with hematoxylin to ascertain neuron and glia (astrocyte) densities. Results: No significant differences in neuronal densities were found between groups. However, a reduction in the density of GFAP immunoreactive astrocytes was observed in the amygdala of subjects with major depressive disorder compared to the bipolar disorder, schizophrenia, and normal control postmortem samples. Conclusions: A decrease in density of GFAP immunoreactive astrocytes in the amygdala of depressed subjects is consistent with prior histologic reports and might contribute to amygdala volume reductions reported in several in vivo neuroimaging studies.

KW - Amygdala

KW - Astrocyte

KW - Bipolar disorder

KW - Depression

KW - Glial cell

KW - Neuron

UR - http://www.scopus.com/inward/record.url?scp=77955610466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955610466&partnerID=8YFLogxK

U2 - 10.1111/j.1399-5618.2010.00838.x

DO - 10.1111/j.1399-5618.2010.00838.x

M3 - Article

VL - 12

SP - 541

EP - 549

JO - Bipolar Disorders

JF - Bipolar Disorders

SN - 1398-5647

IS - 5

ER -